镇脑平肝丸治疗急性脑梗死48例疗效观察

目的:观察镇脑平肝丸治疗急性脑梗死的疗效及其对治疗前后血浆同型半胱氨酸(Hcy)含量的影响.方法:将78例患者随机分为2组.治疗组48例在常规治疗的基础上加用镇脑平肝丸口服,对照组30例采用常规治疗,疗程均为21天.现察2组临床疗效、神经功能缺损评分及治疗前后血浆Hcy含量变化,另设健康对照组30例测Hcy作对比观察.结果:总有效率治疗组为89.58%,对照组为73.33%,2组比较,差异有显著性意义(P<0.05).治疗后2组神经功能缺损评分均有不同程度改善(P<0.05,P<0.01),治疗组改善较对照组更显著(P<0.05);治疗前2组Hcy水平明显高于健康对照组(P<0.05);治疗后2组Hcy水平较治疗前均有不同程度的下降(P<0.05);治疗后2组比较,治疗组Hcy降低明显优于对照组(P<0.05).结论:镇脑平肝丸治疗急性脑梗死疗效显著.

Effect of Zhennao Pinggan Pills for Acute Cerebral Infarction:An Observation of 48 Cases

Objective:To investigate the effect of Zhennao Pinggan Pills (ZPP)for acute cerebral infarction,and to observe its effect on plasma homocys- teine(Hcy).Methods:Seventy-eight acute cerebral infarction patients were random- ized into 2 groups:the treatment group(n=48)received ZPP and routine treat- ment,and the control group(n=30)received routine treatment only.Thirty healthy volunteers served as the health controls.The treatment lasted 21 days.After treatment the therapeutic effect was evaluated and the chan...